Efficacy News and Research

RSS

Increasing access to MRI scanning: an interview with Jane Kilkenny

MRI scanners use strong magnetic fields, radio waves and field gradients to produce cross sectional images throughout the human body.

12 Jul 2016

Hops extract activates chemical pathway in cells to help prevent breast cancer

An enriched hops extract activates a chemical pathway in cells that could help prevent breast cancer, according to new laboratory findings from the UIC/NIH Center for Botanical Dietary Supplements Research at the University of Illinois at Chicago.

12 Jul 2016

Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

Shire plc announces that the U.S. Food and Drug Administration has approved Xiidra (lifitegrast ophthalmic solution) 5%, a twice-daily eye drop solution indicated for the treatment of the signs and symptoms of dry eye disease in adult patients.

12 Jul 2016

New home-based intervention aims to improve health outcomes of children of South Asian immigrants

More than one-third of Bronx residents are born outside of the United States. Often separated from family, challenged by language barriers, unfamiliar with health resources, and burdened by poverty, they are at high risk for health problems. And these risks extend to their young children.

11 Jul 2016

FDA approves new topical retinoid gel for OTC treatment of acne

The U.S. Food and Drug Administration today approved Differin Gel 0.1% (adapalene), a once-daily topical gel for the over-the-counter (OTC) treatment of acne. Differin Gel 0.1% is approved for use in people 12 years of age and older.

8 Jul 2016

Study underscores importance of evidence-based medical care in improving health of neonates

Born too soon, very premature infants are particularly vulnerable and need appropriate care.

8 Jul 2016

Study results pave way to development of effective human vaccine against HIV

A new scientific study conducted by a team of leading AIDS scientists reveal results that lead the way to the development of an effective human vaccine against human immunodeficiency virus (HIV).

8 Jul 2016

New data shows Sandoz biosimilar etanercept candidate has equivalent efficacy to originator product

Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, today announced results from the EGALITY trial in which the primary endpoint of achieving equivalence in Psoriasis Area and Severity Index (PASI) 75 response rates at week 12 was met.

8 Jul 2016

Tumor DNA fragments in blood can help identify risk of colorectal cancer recurrence

Ludwig researchers working in collaboration with colleagues in Australia and the US have shown that fragments of tumor DNA circulating in the blood can be used to gauge the risk of colorectal cancer recurrence and the efficacy of chemotherapy following surgery.

7 Jul 2016

Clinical trial to evaluate safety of palbociclib drug in African American women with breast cancer

The first clinical trial to test a newly approved breast cancer drug specifically in African American patients is now enrolling at Georgetown Lombardi Comprehensive Cancer Center and will begin soon at five other institutions in Washington, DC, Maryland, Alabama and New Jersey.

7 Jul 2016

Scientists discover key cellular mechanism behind side-effects of antipsychotics

Since their development in the 1950s, antipsychotic drugs have been widely used to treat psychoses and neuropsychiatric disorders like schizophrenia. A debilitating side-effect of these drugs called parkinsonism limits their efficacy.

7 Jul 2016

Phase 1 trial to examine efficacy of promising malaria vaccine in Burkina Faso

Malaria is one of the world's deadliest diseases: it infects hundreds of millions of people every year, and kills about half a million, most of them under five years of age.

6 Jul 2016

Zinc acetate lozenges may be effective in treating common cold

Zinc acetate lozenges may reduce the duration of the common cold by nearly 3 days, according to a recent analysis.

6 Jul 2016

Scientists use Sure Chill technology to develop cost-effective vaccine storage

Vaccines against killer diseases from polio to hepatitis are fragile and can easily be made useless if they get too hot or too cold.

6 Jul 2016

Researchers identify potential biomarker for Parkinson's disease in biobanked urine samples

For more than five years, urine and cerebral-spinal fluid samples from patients with Parkinson's disease have been locked in freezers in the NINDS National Repository, stored with the expectation they might someday help unravel the still-hidden course of this slow-acting neurodegenerative disease.

6 Jul 2016

New report reveals lack of attention in implementing government recommendations on end of life care

On the same day as the Government will respond to the Review into Choice at the End of Life, a new report reveals that, despite an abundance of government recommendations on end of life care in England, not enough attention has been given to how policies are implemented and there is uncertainty in terms of whether they have actually led to improvements in patient care.

6 Jul 2016

Penn researchers develop low-cost genetic test for Zika virus

University of Pennsylvania engineers have developed a rapid, low-cost genetic test for the Zika virus.

6 Jul 2016

University report explores efficacy of palliative care in England

A new report by Sheffield Hallam University has revealed that, despite an abundance of government recommendations on end of life care in England, there is uncertainty as to whether they have led to improvements in patient care.

From Sheffield Hallam University 6 Jul 2016

Alnylam reports new results from investigational RNAi therapeutic programs

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today preliminary results from its ongoing Phase 2 open-label extension (OLE) studies with patisiran and revusiran, both investigational RNAi therapeutics targeting transthyretin (TTR) for the treatment of hereditary TTR-mediated amyloidosis (hATTR amyloidosis).

6 Jul 2016

JACC publishes pivotal data on Tryton’s dedicated coronary bifurcation stent, results submitted to FDA

Tryton Medical, Inc., the leading developer of stents designed to treat coronary bifurcation lesions, today announced that results from the Tryton Confirmatory Study of the company’s Side Branch Stent have been published in JACC Cardiovascular Interventions.

6 Jul 2016

Efficacy News and Research

Increasing access to MRI scanning: an interview with Jane Kilkenny

Hops extract activates chemical pathway in cells to help prevent breast cancer

Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

New home-based intervention aims to improve health outcomes of children of South Asian immigrants

FDA approves new topical retinoid gel for OTC treatment of acne

Study underscores importance of evidence-based medical care in improving health of neonates

Study results pave way to development of effective human vaccine against HIV

New data shows Sandoz biosimilar etanercept candidate has equivalent efficacy to originator product

Tumor DNA fragments in blood can help identify risk of colorectal cancer recurrence

Clinical trial to evaluate safety of palbociclib drug in African American women with breast cancer

Scientists discover key cellular mechanism behind side-effects of antipsychotics

Phase 1 trial to examine efficacy of promising malaria vaccine in Burkina Faso

Zinc acetate lozenges may be effective in treating common cold

Scientists use Sure Chill technology to develop cost-effective vaccine storage

Researchers identify potential biomarker for Parkinson's disease in biobanked urine samples

New report reveals lack of attention in implementing government recommendations on end of life care

Penn researchers develop low-cost genetic test for Zika virus

University report explores efficacy of palliative care in England

Alnylam reports new results from investigational RNAi therapeutic programs

JACC publishes pivotal data on Tryton’s dedicated coronary bifurcation stent, results submitted to FDA

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News